Crude is rising, dollar is strengthening again, US bond yields are rising, the US-China trade deal is not so good for India at least sentimentally and from a flows perspective, and the recent geopolitical stress has also taken out some shine from India. Valuation premiums could contract for India in the near to medium term and given that we do not have much upside room in terms of valuation left, we could be in a very narrow range market.
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while
October 30, 2026